Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market. "We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it." 23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."

Share:
More In Technology
Connectivity Solutions Provider Credo Goes Public on Nasdaq
High-speed connectivity solutions provider Credo went public on the Nasdaq on Thursday, raising $200 million in its IPO. CEO Bill Brennan, joined Cheddar to discuss its entry into the capital markets and the next chapter for the company. "We're going to be focused on what we have been focused on, which is really creating, creating innovative connectivity solutions that really pushed the edge on efficient power as well as very effective cost," he said.
BD Veritor Hopes to Take 'Guesswork' Out With Smartphone-Enabled COVID Test
BD Veritor is a variation of the at-home COVID test that uses a smartphone to interpret the results. The test is taken via a nose swab test strip that is then scanned by your phone’s camera with the result clearly displayed as positive or negative. James Walker, vice president of integrated diagnostics USA for BD, joined Cheddar to discuss how the test hopefully takes the "guesswork out of testing." Walker also went into what BD is doing to deal with the surging demand for at-home tests amid the omicron spread. "While we don't disclose how much we produce, we have capacity to manufacture up to 12 million rapid antigen tests per month and are delivering on our commitments to distributors and retailers," he said.
Crowdbotics Raises $22M Series A to Enable Anyone to Turn Ideas Into Apps
Low-code app development platform Crowdbotics raised $22 million in a Series A funding round led by Jackson Square Ventures. Crowdbotics has helped more than 14,000 customers launch apps without having to learn how to code. The company can offer a team of expert developers to help companies launch custom apps, or provide the means for companies to develop apps themselves. Crowdbotics CEO Anand Kulkarni joined Cheddar News' Closing Bell to discuss.
Robotics for Eyelash Extensions; Innovation in Food Tech
On this episode of Cheddar Innovates: Sidechef CEO breaks down how it's building a platform to make recipe shopping easy; Luum CEO explains the process of having a robot put on eyelash extensions; A look at Curiosity Stream's new original series, 'Evolve.'
Load More